Life Sciences

How Will Healthcare Dealmaking Adapt to the Liquidity Squeeze?
Business How Will Healthcare Dealmaking Adapt to the Liquidity Squeeze?

The healthcare sector, like many others, faces a challenging environment due to ongoing liquidity constraints. Venture capitalists and dealmakers are navigating through a period marked by tightened exit strategies, heightened valuations, and an overall unique set of dynamics. A recent Deloitte report sheds light on these pressing challenges and

October 28, 2024
Can Gene Therapy Revolutionize Hemophilia B Treatment Forever?
Care Can Gene Therapy Revolutionize Hemophilia B Treatment Forever?

Gene therapy has emerged as a revolutionary tool in modern medicine, offering new hope for individuals with genetic disorders. One such breakthrough is its application in treating hemophilia B, a rare and often debilitating blood disorder. But can gene therapy truly revolutionize the treatment for hemophilia B, making a lasting impact on those

September 26, 2024
Can AI Startups Overcome Hurdles in the Healthcare Sector?
Care Can AI Startups Overcome Hurdles in the Healthcare Sector?

AI startups targeting the healthcare sector have shown great promise in recent years, but they must navigate unique challenges to succeed. While the potential for innovation in clinical care, administrative efficiencies, and patient outcomes is immense, these startups must overcome several key obstacles to reach maturity and make a significant

September 17, 2024
EU AI Act Revolutionizes Healthcare, Focusing on Safety and Fairness
Public Policy EU AI Act Revolutionizes Healthcare, Focusing on Safety and Fairness

The European Union's pioneering AI Act, poised to dramatically alter the landscape of healthcare and life sciences across Europe, shines a spotlight on the urgent need for compliance among companies involved in AI applications from production to clinical operations. As the regulation drives towards harmonized rules on artificial intelligence,

August 30, 2024
Can Lenmeldy’s High Cost Be Justified by Its Life-Saving Benefits?
Care Can Lenmeldy’s High Cost Be Justified by Its Life-Saving Benefits?

Gene therapy has ushered in a new era of medical possibilities, offering groundbreaking treatments for debilitating and often fatal diseases. One of the most prominent examples is Lenmeldy (atidarsagene autotemcel), a gene therapy developed by Orchard Therapeutics and recently acquired by Kyowa Kirin, designed to combat metachromatic

August 23, 2024
How Can We Ensure Comprehensive Pharmaceutical Safety Today?
Care How Can We Ensure Comprehensive Pharmaceutical Safety Today?

Pharmaceutical safety is a multifaceted and crucial aspect of public health, involving systematic efforts, regulations, and the collective responsibility of individuals. Ensuring the efficacy and safety of drugs requires vigilance from regulatory bodies, healthcare professionals, the pharmaceutical industry, and the public. This article delves

August 22, 2024
Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for subscribing.
We'll be sending you our best soon.
Something went wrong, please try again later